Autres langues Terumo Corporation

Actions

4543

JP3546800008

Equipement, fournitures et distribution médicale

Marché Fermé - Japan Exchange 08:30:00 08/05/2026 Varia. 5j. Varia. 1 janv.
1 972,50 JPY +0,79 % Graphique intraday de Terumo Corporation -0,83 % -13,11 %

Autres langues

30/04 Terumo : Issued its First U.S. Dollar-Denominated Senior Unsecured Notes
22/04 Humacyte, Inc. Announces the Appointment of Jim Mercadante as Chief Commercial Officer
15/04 Terumo Corporation Joins the Healthcare Plastics Recycling Council
09/04 Terumo Deepens Costa Rica Investment Amid Medtech Growth
19/03 Tata Elxsi and Terumo Corporation Launch Global Offshore Development Center
19/03 Tata Elxsi launches global offshore development center for Terumo Corporation
02/03 Shoulder Innovations, Inc. Announces Board and Committee Changes, Effective February 26, 2026
25/02 Galderma Announces Triple Approval of New Restylane Syringe in the EU, the U.S., and Canada
19/02 Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships
16/02 Terumo : Q&A Session at the Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026
16/02 Terumo : Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026 (FY2025)(with note)
13/02 Terumo : Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026 (FY2025)
13/02 Terumo : IFRS Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026
13/02 Terumo Corporation Reports Earnings Results for the Nine Months Ended December 31, 2025
10/02 Cartera Asiática: Últimas compras
10/02 Portafoglio Asia: nuovi acquisti
10/02 Neue Käufe im Asien-Pazifik-Portfolio
10/02 New purchases in the Asia-Pacific Investor portfolio
10/02 Veranderingen in de Aziatische beleggingsportefeuille
16/01 Terumo : J.P. Morgan Healthcare Conference 2026
14/01 PRESSWIRE 2023: Diabeloop and Sequel Med Tech Enter Partnership to Integrate FDA-Cleared DBLG2 into the twiistâ„¢ Automated Insulin Delivery System
13/01 Terumo : 44th J.P.Morgan Healthcare Conference
06/01 Terumo launches Surtract(TM) safety syringe in the United States
12/12 Market Outlook: Injectable Drug Delivery Industry to Top US$1,034.78 Billion by 2030
13/11 US Shutdown End, FX, Earnings Nudge Asian Markets Higher
Aucun résultat pour cette recherche
🔇